Similar articles

• [The role of superantigens in rheumatic disease].

  Miyata M, Uchiyama T, Kasukawa R. Miyata M, et al. Ryumachi. 1996 Jun;36(3):598-604. Ryumachi. 1996. PMID: 8779799 Review. Japanese. No abstract available.
• Early diagnosis of staphylococcal toxic shock syndrome by detection of the TSST-1 Vbeta signature in peripheral blood of a 12-year-old boy.

  Ferry T, Thomas D, Bouchut JC, Lina G, Vasselon-Raina M, Dauwalder O, Gillet Y, Vandenesch F, Floret D, Etienne J. Ferry T, et al. Pediatr Infect Dis J. 2008 Mar;27(3):274-7. doi: 10.1097/INF.0b013e31815c93a3. Pediatr Infect Dis J. 2008. PMID: 18277923
• Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.

  Arad G, Levy R, Hillman D, Kaempfer R. Arad G, et al. Nat Med. 2000 Apr;6(4):414-21. doi: 10.1038/74672. Nat Med. 2000. PMID: 10742148
• A severe case of neonatal toxic shock syndrome-like exanthematous disease with superantigen-induced high T cell response.

  Miki M, Uchiyama T, Kato H, Nishida H, Takahashi N. Miki M, et al. Pediatr Infect Dis J. 2006 Oct;25(10):950-2. doi: 10.1097/01.inf.0000238144.22201.4a. Pediatr Infect Dis J. 2006. PMID: 17006297
• The pathogenesis of Kawasaki disease and superantigens.

  Uchiyama T, Kato H. Uchiyama T, et al. Jpn J Infect Dis. 1999 Aug;52(4):141-5. Jpn J Infect Dis. 1999. PMID: 10592892 Review.